Tag archive for ‘Copaxone 40 mg’
Jewish Business News Correspondent On Thursday, September 11th, 2014

Teva finds double-dose Copaxone halves side-effects

– A 50% reduction in adverse side-effects was reported with the three-times-a-week 40 mg MS injection. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has published results More...

Jewish Business News On Sunday, August 10th, 2014

Teva to sue Dr. Reddy’s over generic Copaxone

– Teva confirmed that it will continue to vigorously defend its Copaxone intellectual property rights. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has confirmed that More...

Gali Raz On Wednesday, July 31st, 2013

UK Court of Appeal rules in favor of Teva regarding Copaxone patents

– Teva Pharmaceutical Industries Ltd. has chalked up a victory in the UK against Mylan Inc., stating that their Copaxone patents are valid through May 2015, after losing a similar court case in the More...

Wordpress site Developed by Fixing WordPress Problems